2024-520324-29-00招募中2 期
PLatelet aggregation and Aspirin low response in Type One Diabetes and the association with vascular damage and diabetic Nephropathy
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 332
- 试验地点
- 1
- 主要终点
- Investigate platelet aggregation in T1D without/off aspirin treatment, stratified according to degree of albuminuria, compared to healthy controls. Platelet aggregation is determined by arachidonic acid expressed as area under the curve.
研究概览
简要总结
Investigate platelet aggregation in T1D without/off aspirin treatment, stratified according to degree of albuminuria, compared to healthy controls. Platelet aggregation is determined by arachidonic acid expressed as area under the curve.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 是
入选标准
- •Type 1 diabetes. (Only for the type 1 diabetes population.)
- •Male and female participants > 18 years of age.
- •Capable of giving informed consent
排除标准
- •Pregnancy or breastfeeding
- •Intake of any antithrombotic medication or fish oil, or intake of NSAIDs within the past 14 days. (Only healthy controls.)
- •Persons who, in the judgement of the investigator, are incapable of participating.
- •Participation in another intervention study
- •Non-diabetic kidney disease. (Only the type 1 diabetes population.)
- •Treatment with adenosine diphosphate ADP-receptor inhibitors, NSAID within the past 14 days, fish oil or other antithrombotic treatment, e.g. vitamin K antagonists and NOAKs. Only the type 1 diabetes population.
- •Liver disease (liver cirrhosis with current impaired liver function defined as ALAT more than two times the upper limit at last control.) (Only the type 1 diabetes population.)
- •High risk of thrombosis, i.e., Stroke, TIA or drug eluting stent within the last 6 months or acute coronary syndrome within the last 6 weeks or within 12 months from complications to acute coronary syndrome. (Only the type 1 diabetes population.)
- •Known hypersensitivity or intolerance to aspirin. (Only the type 1 diabetes population.)
- •Chronic systemic disease. (Only healthy controls.)
结局指标
主要结局
Investigate platelet aggregation in T1D without/off aspirin treatment, stratified according to degree of albuminuria, compared to healthy controls. Platelet aggregation is determined by arachidonic acid expressed as area under the curve.
Investigate platelet aggregation in T1D without/off aspirin treatment, stratified according to degree of albuminuria, compared to healthy controls. Platelet aggregation is determined by arachidonic acid expressed as area under the curve.
次要结局
- Investigate platelet aggregation after a minimum of seven days aspirin treatment in T1D, stratified according to degree of albuminuria, compared to healthy controls.
- Determine the prevalence of plaques and plaque volume in the carotid arteries in subjects with T1D.
- Examine the association between platelet aggregation and the plaque volume in the carotid arteries in subjects with T1D.
- Investigate whether platelet aggregation or plaque volume can predict progression in plaque volume after two years, independently of other risk factors.
- Investigate if platelet aggregation and change in plaque volume can predict CVD outcome in register-based follow up, independently of other risk factors.
- Investigate endothelial function and inflammation in T1D and examine the association with platelet aggregation and plaque volume in the carotid arteries.
研究者
Peter Rossing
Scientific
Steno Diabetes Center Copenhagen
研究点 (1)
Loading locations...
相似试验
招募中
Unknown
Effectiveness of aspirin in children undergoing heart surgeryAspirin resistanceCardiovascular - Other cardiovascular diseasesCongenital heart diseaseACTRN12623001208695Children's Health Queensland Hospital and Health Service132
已完成
不适用
Evaluation of the effect of aspirin on platelet aggregation and coagulation parameters in healthy male volunteerscoagulationplatelet aggretion10064477NL-OMON34607Centre for Human Drug Research6
已完成
1 期
The effect of low dose aspirin on platelet inhibition in patients with rheumatoid arthritisCondition 1: Rheumatoid arthritis. Condition 2: Rheumatoid arthritis.Rheumatoid arthritis, unspecifiedIRCT201707293812N6Connective Tissue research Center- Tabriz University of Medical Sciences45
招募中
3 期
PRACTICAL TRIAACTRN12605000581662Cardiology Dept, Royal Perth Hospital370
已完成
4 期
The effects of aspirin on the platelet function of healty volunteers and of patients with occlusive arterial vascular disease.NL-OMON31793Academisch Ziekenhuis Maastricht36